SNN logo

Smith & Nephew SNATS Inc. (SNN)

$29.39

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on SNN

Market cap

$12.62B

EPS

0.56

P/E ratio

23.1

Price to sales

2.29

Dividend yield

3.28%

Beta

0.550987

Price on SNN

Previous close

$30.08

Today's open

$29.91

Day's range

$29.37 - $29.94

52 week range

$28.80 - $38.79

Profile about SNN

CEO

Deepak Nath

Employees

17349

Headquarters

Watford,

Exchange

New York Stock Exchange

Shares outstanding

424862010

Issue type

American Depository Receipt

SNN industries and sectors

Healthcare

Medical Equipment & Supplies

News on SNN

Smith & Nephew plc (SNN) Shareholder/Analyst Call Transcript

Smith & Nephew plc (SNN) Shareholder/Analyst Call Transcript

news source

Seeking Alpha • Jun 11, 2026

news preview

Smith & Nephew's robotics push wins surgeon backing

Smith & Nephew PLC (LSE:SN) efforts to expand its surgical robotics platform and strengthen its orthopaedics pipeline received a vote of confidence from surgeons at a recent investor event, according to analysts at JPMorgan. Analyst Veronika Dubajova said discussions at the medical technology group's Expert Surgeon Insights event in London left her incrementally more positive on the prospects for CORI, Smith & Nephew's robotic-assisted surgery platform.

news source

Proactive Investors • Jun 10, 2026

news preview

Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, announces the completion of the first clinical cases performed using the next‑generation CORI◊ XT Handheld Robotics Platform, marking an important milestone in the clinical introduction of its latest handheld robotics technology. CORI XT Handheld Robotic Platform is designed to be the single handheld robotics platform for all orthopaedic needs - partial to revision knee, hip*, and anatomic and reverse shoulders - with a footprint tailored to the unique needs of hospitals and ambulatory surgical suites settings.

news source

GlobeNewsWire • Jun 8, 2026

news preview

Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the US launch of next generation LEAF ♢ Patient Monitoring System, a data-driven pressure injury prevention platform designed to help health care providers tackle the growing burden of hospital-acquired pressure injuries (HAPIs) by strengthening protocols and outcomes. The LEAF System uses a wearable sensor to monitor patient mobility and provide real-time turn status updates, helping to improve workflow efficiency, turn quality, and protocol adherence.1-3

news source

GlobeNewsWire • Jun 1, 2026

news preview

VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership

Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.

news source

Zacks Investment Research • May 13, 2026

news preview

UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises

Medical products maker ​Smith+Nephew posted ‌a 3.1% rise ​in ​first-quarter underlying revenue on ⁠Wednesday, ​helped by ​strong sports medicine and wound ​management ​performance, and kept ‌its ⁠annual outlook unchanged while announcing ​a $500 ​million ⁠share buyback.

news source

Reuters • May 6, 2026

news preview

Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript

Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript

news source

Seeking Alpha • May 6, 2026

news preview

Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming European Wound Management Association (EWMA) Conference, Bremen between 6-8 May 2026.

news source

GlobeNewsWire • May 5, 2026

news preview

SNN vs. BSX: Which Stock Is the Better Value Option?

Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?

news source

Zacks Investment Research • May 5, 2026

news preview

SNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year Study

Smith+Nephew's CARTIHEAL implant shows superior 5-year outcomes vs. standard care, with a new CPT code set to boost adoption and expand cartilage repair reach.

news source

Zacks Investment Research • Apr 24, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Smith & Nephew SNATS Inc.

Open an M1 investment account to buy and sell Smith & Nephew SNATS Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in SNN on M1